The Prognostic Value of NANO Scale Assessment in IDH-Wild-Type Glioblastoma Patients
BackgroundIDH-wild-type glioblastoma (GBM) is the most frequent brain-derived malignancy. Despite intense research efforts, it is still associated with a very poor prognosis. Several parameters were identified as prognostic, including general physical performance. In neuro-oncology (NO), special emp...
Guardado en:
Autores principales: | Johannes Kasper, Tim Wende, Michael Karl Fehrenbach, Florian Wilhelmy, Katja Jähne, Clara Frydrychowicz, Gordian Prasse, Jürgen Meixensberger, Felix Arlt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94775bf4170e40539cce2cad00e99203 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
por: Tim Wende, et al.
Publicado: (2021) -
SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme
por: Sophie Guelfi, et al.
Publicado: (2021) -
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
por: Rebekka Spellerberg, et al.
Publicado: (2021) -
Expression Levels of RAD51 Inversely Correlate with Survival of Glioblastoma Patients
por: Christopher Morrison, et al.
Publicado: (2021) -
Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells
por: Laura Martínez-Escardó, et al.
Publicado: (2021)